Table 2.
Demographic and clinical characteristics of Crohn's disease and ulcerative colitis patients.
| Variable | Non-inflamed Controls (n=30) | Inactive UC patients (n=20) | Active UC patients (n=30) | Inactive CD patients (n=10) | Active CD patients (n=10) |
|---|---|---|---|---|---|
| Age, years | |||||
| Mean | 48.9 | 40.8 | 39.05 | 49.3 | 25 |
| Sex, | 14/16 | 6/14 | 10/20 | 4/6 | 3/7 |
| female/male | |||||
| Treatment | |||||
| Mesalazine | ND | 19/20 | 19/30 | 1/10 | 1/10 |
| Azathioprine | ND | 4/20 | 1/30 | 5/10 | 3/10 |
| Prednisone | ND | 3/20 | 3/30 | 2/10 | 1/10 |
| Mercaptopurine | ND | 0/20 | 3/30 | 0/10 | 1/10 |
| Disease | |||||
| Extension | ND | 7/20 | 1/30 | 1/10 | 0/10 |
| Distal colitis | ND | 12/20 | 8/30 | 7/10 | 6/10 |
| Pancolitis | |||||
| Extra-intestinal | |||||
| manifestations | |||||
| absent | ND | 15/20 | 17/30 | 7/10 | 6/10 |
| present | ND | 4/20 | 12/30 | 1/10 | 0/10 |
CD: Crohn's Disease patient group; UC: ulcerative colitis patient group. ND: not determined.